Precipio, Inc. Common Stock (PRPO)
Precipio, Inc. is a biotechnology company specializing in diagnostic and testing services for cancer and infectious diseases. It develops and offers cutting-edge laboratory techniques, including oncology diagnostics and pathogen testing, aimed at improving patient outcomes through innovative and high-quality testing solutions.
Company News
Precipio reported Q2-2025 revenues of $5.7M, a 27% year-over-year increase, with improvements in both Products and Pathology Services divisions. The company expects to end the year cash flow positive and debt-free, driven by revenue growth and cost management.
U.S. stocks traded higher toward the end of trading, with Dow Jones gaining more than 150 points on Thursday. The Dow traded up 0.53% to 33,844.18 while the NASDAQ rose 0.90% to 13,223.26. The S&P 500, also rose, gaining, 0.57% to 4,291.82. Check This Out: Top 5 Tech Stocks That You May Want To Dump In Q2 Â Leading and Lagging Sectors Consumer...
Which penny stocks are you watching right now? The post Best Penny Stocks to Buy Today? 3 For Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.